Efficacy and Safety of Avatrombopag in Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

• Main Authors: Chunlu Li (Author), Xiaoxuan Li (Author), Feihong Huang (Author), Jing Yang (Author), Anguo Wu (Author), Long Wang (Author), Dalian Qin (Author), Wenjun Zou (Author), Jianming Wu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2019-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Avatrombopag is a novel oral, nonpeptide thrombopoietin receptor agonist (TPO-RA). A few studies have shown that avatrombopag is effective against thrombocytopenia. However, no systematic review has been conducted on the efficacy and safety of avatrombopag. Therefore, the aim of this stu...